Literature DB >> 7461495

Epidemiological differences between adenocarcinoma and squamous cell carcinoma of the uterine cervix.

M O Korhonen.   

Abstract

Entities:  

Mesh:

Year:  1980        PMID: 7461495     DOI: 10.1016/0090-8258(80)90099-2

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  6 in total

Review 1.  Practical issues related to uterine pathology: in situ and invasive cervical glandular lesions and their benign mimics: emphasis on cytology-histology correlation and interpretive pitfalls.

Authors:  David C Wilbur
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

2.  Sexual, reproductive, and other risk factors for adenocarcinoma of the cervix: results from a population-based case-control study (California, United States)

Authors:  G Ursin; M C Pike; S Preston-Martin; G d'Ablaing; R K Peters
Journal:  Cancer Causes Control       Date:  1996-05       Impact factor: 2.506

3.  Squamous and adenocarcinoma of the uterine cervix: a comparison using routine data.

Authors:  P B Silcocks; H Thornton-Jones; M Murphy
Journal:  Br J Cancer       Date:  1987-03       Impact factor: 7.640

4.  Features of postmenopausal uterine haemorrhage.

Authors:  Sebija Izetbegovic; Goran Stojkanovic; Nihad Ribic; Eldar Mehmedbasic
Journal:  Med Arch       Date:  2013-12-28

5.  A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland.

Authors:  M Hinkula; E Pukkala; P Kyyrönen; P Laukkanen; P Koskela; J Paavonen; M Lehtinen; A Kauppila
Journal:  Br J Cancer       Date:  2004-03-08       Impact factor: 7.640

6.  Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National Case-Control Study of Cervical Cancer.

Authors:  J Green; A Berrington de Gonzalez; S Sweetland; V Beral; C Chilvers; B Crossley; J Deacon; C Hermon; P Jha; D Mant; J Peto; M Pike; M P Vessey
Journal:  Br J Cancer       Date:  2003-12-01       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.